Evaluation of a supportive care program for elderly patients with digestive cancer

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study involves elderly patients aged 75 and older who are hospitalized at the Strasbourg Europe Cancerology Institute and are starting chemotherapy or targeted therapy for digestive cancer. It aims to assess the impact of an early multidisciplinary supportive care program, known as EPODIG-G, which coordinates existing supportive care services at the institute. The study is designed as a monocentric, comparative, open-label, randomized parallel group trial to evaluate the benefits of this program when initiated prior to therapeutic treatment.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients must be ≥ 75 years old
* Performance status 0, 1 or 2
* Diagnostic of digestive cancer, all stages (adjuvant or metastatic), with an indication for chemotherapy treatment or targeted therapy for a treatment period of 24 weeks or more
* Patients previously treated with one or several lines of chemotherapy for this digestive cancer are eligible
* Estimated life expectancy ≥ 3 months
* Patients able to speak, read and understand French
* Signed informed consent from the patient
* Patients must have a social security coverage

Exclusion Criteria:

* History of differentiated neuroendocrine tumors grade 1 or 2 (pancreas, small intestine)
* Cancer currently being treated (except for hormone therapy) other than current digestive cancer
* History of major surgery and/or curative radiation therapy during the last 4 weeks before inclusion
* Patients unable to submit to medical follow-up for geographical, social or psychological reasons
* Patients placed under guardianship

Where it's running

• Institut de cancérologie Strasbourg Europe
  Strasbourg, France Recruiting

Study contacts

• Study coordinator: Valérie SARTORI
• Email: v.sartori@icans.eu
• Phone: 368767223

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Registry for patients with unresectable pancreatic cancer treated with OncoSil™

  This study is testing how well the OncoSil™ device works and its safety for people with advanced pancreatic cancer who are also receiving chemotherapy.

  Recruiting at 5 sites OncoSil Medical Limited · Las Palmas de Gran Canaria and 8 other locations · NCT04493632

• HR20013 for preventing nausea and vomiting in cancer patients receiving chemotherapy

  This real-world study tests whether HR20013 helps prevent nausea and vomiting in adults with cancer who are getting chemotherapy.

  Recruiting Sun Yat-sen University · Guangzhou, Guangdong · NCT07874308

• Methylscape test in body fluids for multi-cancer detection in Colombia

  A simple blood, urine, or saliva test called Methylscape is being tested to see if it can detect multiple cancers and identify where the signal is coming from, using people with cancer and healthy volunteers in Colombia.

  Recruiting Centro de Tratamiento e Investigación sobre Cáncer, Luis Carlos Sarmiento Angulo · Bogotá, Bogota D.C. · NCT07741435

• Ready for Safe Cancer Treatment (RESET): A comprehensive perioperative program for surgical patients

  The RESET program tests a structured, multidisciplinary perioperative plan to improve safety and recovery for adults having planned cancer surgery and older adults having planned non cancer-related surgery.

  Recruiting at 2 sites Regional Specialist Hospital in Wroclaw · Wroclaw, Lower Silesian Voivodeship and 1 other locations · NCT07727876

• How environment and biology together predict health, aging, and death

  Researchers are following adults to see how living conditions and biology together relate to aging and life expectancy, by linking personal health data with environmental and social information over time.

  Recruiting Longevity Metrics, Inc. · Boulder, Colorado · NCT07646782

• Metastatic liver cancer patient registry from multiple Chinese centers

  This is a registry that collects real-world data on adults with liver metastases to understand patterns and prognosis and to support future research.

  Recruiting at 2 sites Anhui Provincial Hospital · Bengbu, Anhui and 2 other locations · NCT07602504

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.